Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Cheng

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Plos Neglected Tropical Diseases|January 9, 2026
An automated end-to-end system for schistosome viability assessment to accelerate anti-schistosomal drug discoveryPing Liu, Wenjun Cheng, Yuepeng Wang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 9, 2023
CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancerYuwei Cao, Yi Jiang, Jiacheng Song, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 16, 2024
Beyond monotherapy: An era ushering in combinations of PARP inhibitors with immune checkpoint inhibitors for solid tumorsLin Zhou, Yicong Wan, Lin Zhang, et al.
Medical Oncology (Northwood, London, England)|June 20, 2014
Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulationLin Zhang, Yicong Wan, Yi Jiang, et al.
Parasitology Research|October 20, 2020
Mechanism by which the combination of SjCL3 and SjGAPDH protects against Schistosoma japonicum infectionWenling Huang, Mengjie Gu, Wenjun Cheng, et al.
Molecular and Clinical Oncology|September 3, 2019
Analysis of the risk factors of residual lesions after conization and prognosis of multifocal micro-invasive squamous cell cervical carcinoma treated with different types of surgeryChengyan Luo, Jiangnan Qiu, Jie Zhang, et al.
Frontiers in Genetics|November 12, 2019
Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics AnalysisJinhui Liu, Huangyang Meng, Siyue Li, et al.
Cancer Letters|June 16, 2024
YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modificationHuangyang Meng, Huixian Miao, Yashuang Zhang, et al.
Journal of Materials Chemistry. B|June 17, 2026
A hybrid membrane-camouflaged CuS nanoplatform for synergistic nanotherapy of ovarian cancer <i>via</i> chemodynamic and sonodynamic effectsYuxin Jiang, Runzi Guo, Zhaojun Cui, et al.
Genomics|September 5, 2020
Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment explorationJinhui Liu, Huangyang Meng, Sipei Nie, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Plos Neglected Tropical Diseases|January 9, 2026
An automated end-to-end system for schistosome viability assessment to accelerate anti-schistosomal drug discoveryPing Liu, Wenjun Cheng, Yuepeng Wang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 9, 2023
CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancerYuwei Cao, Yi Jiang, Jiacheng Song, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 16, 2024
Beyond monotherapy: An era ushering in combinations of PARP inhibitors with immune checkpoint inhibitors for solid tumorsLin Zhou, Yicong Wan, Lin Zhang, et al.
Medical Oncology (Northwood, London, England)|June 20, 2014
Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulationLin Zhang, Yicong Wan, Yi Jiang, et al.
Parasitology Research|October 20, 2020
Mechanism by which the combination of SjCL3 and SjGAPDH protects against Schistosoma japonicum infectionWenling Huang, Mengjie Gu, Wenjun Cheng, et al.
Molecular and Clinical Oncology|September 3, 2019
Analysis of the risk factors of residual lesions after conization and prognosis of multifocal micro-invasive squamous cell cervical carcinoma treated with different types of surgeryChengyan Luo, Jiangnan Qiu, Jie Zhang, et al.
Frontiers in Genetics|November 12, 2019
Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics AnalysisJinhui Liu, Huangyang Meng, Siyue Li, et al.
Cancer Letters|June 16, 2024
YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modificationHuangyang Meng, Huixian Miao, Yashuang Zhang, et al.
Journal of Materials Chemistry. B|June 17, 2026
A hybrid membrane-camouflaged CuS nanoplatform for synergistic nanotherapy of ovarian cancer <i>via</i> chemodynamic and sonodynamic effectsYuxin Jiang, Runzi Guo, Zhaojun Cui, et al.
Genomics|September 5, 2020
Identification of a prognostic signature of epithelial ovarian cancer based on tumor immune microenvironment explorationJinhui Liu, Huangyang Meng, Sipei Nie, et al.
Pageof 17